Literature DB >> 26065725

Protein Profiling of Women with Spontaneous Preterm Birth.

Langmia Immaculate Mbongo1, Apalasamy Yamunah Devi, Shamsul Zain, Siti Zawiah Omar, Zahurin Mohamed.   

Abstract

BACKGROUND: Preterm birth (PTB) is the largest cause of neonatal mortality and morbidity in the world. Ethnicity disparity in the occurrence of PTB has been associated with the cytokine function. In this study, we aimed at examining cytokine levels in women with spontaneous preterm and term births.
METHOD: Women with spontaneous preterm birth (SPTB) between 24 and 31 weeks (n = 40) and women with spontaneous term birth between 37 and 41 weeks (n = 40) admitted to the University of Malaya Medical Centre from 2011 to 2013 were involved in this study. Plasma proteins were determined for 35 cytokines using ProcartaPlex™ immunoassay. Protein levels were compared between women with SPTB and women with term birth. RESULT: Six specific cytokines were significantly high among women with SPTB. This includes TNFA (odds ratio (OR) 3.4, 95% confidence interval (CI) 2.0-6.0, p = 0.001), MCP-3 (OR 2.5, 95% CI 1.29-4.67, p = 0.007), IL16 (OR 2.4, 95% CI 1.34-4.30, p = 0.003), IL17A (OR 2.3, 95% CI 1.28-4.06, p = 0.005), IFNG (OR 3.8, 95% CI 2.0-8.0, p = 0.001), and farctalkine (OR 2.1, 95% CI 1.17-4.22, p = 0.031), respectively.
CONCLUSION: This study identifies high levels of specific cytokines in women with PTB. These inflammatory biomarkers may play an important role in the mechanisms that result in uterine contraction and PTB.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26065725     DOI: 10.1159/000430857

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  1 in total

1.  Cytokine Patterns in Maternal Serum From First Trimester to Term and Beyond.

Authors:  Anders Hagen Jarmund; Guro Fanneløb Giskeødegård; Mariell Ryssdal; Bjørg Steinkjer; Live Marie Tobiesen Stokkeland; Torfinn Støve Madssen; Signe Nilssen Stafne; Solhild Stridsklev; Trine Moholdt; Runa Heimstad; Eszter Vanky; Ann-Charlotte Iversen
Journal:  Front Immunol       Date:  2021-10-14       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.